Red wine researcher accused of falsifying data

January 11, 2012 By STEPHANIE REITZ , Associated Press

A University of Connecticut researcher known for his work on red wine's benefits to cardiovascular health falsified his data in more than 100 instances, university officials said Wednesday.

UConn officials said nearly a dozen scientific journals are being warned of the potential problems after publishing his studies in recent years.

The researcher, Dr. Dipak Das, did some studies of resveratrol, an ingredient in that has shown potential for promoting health.

But Dr. Nir Barzilai, whose research team conducts resveratrol research at the Albert Einstein College of Medicine in New York, told The Associated Press that Das is not a major figure in the field. The new allegations will not make a material difference to resveratrol research, which is being conducted extensively around the world with encouraging results from many labs, Barzilai said.

Enthusiasm in the potential health benefits from grew after a widely reported study in 2006 in which obese mice lived longer, healthier lives after getting resveratrol. Das was not involved in that research.

UConn officials said their internal review found 145 instances over seven years in which Das fabricated, falsified and manipulated data, and the U.S. Office of Research Integrity has launched an independent investigation of his work.

It wasn't immediately known Wednesday whether the irregularities in Das' research were significant enough to alter the conclusions.

Das is director of UConn Health Center's Cardiovascular Research Center. Eleven scientific research journals that have published Das' work are being notified of the problems, which came to light after a three-year review sparked by an anonymous complaint in 2008 of potential irregularities in his research.

"We have a responsibility to correct the scientific record and inform peer researchers across the country," Philip Austin, interim vice president for , said in a written statement about the notifications to the 11 .

The university's health center recently declined to accept $890,000 in federal grants awarded to Das as its review was under way, and has frozen all other external funding for his lab.

Dismissal proceedings have also been launched against Das, who has been employed by the Health Center since 1984 and was granted tenure in 1993. Das could not immediately be reached Wednesday, and messages were left for him through the union representing him.

Das' other specialty areas besides resveratrol include medicines derived from plants, the molecular structure of plants and herbs and their effect on heart disease, and a nutrient found in Vitamin E that has shown promise fighting free radicals.

He also gained attention in 2009 after publishing a study that concluded crushed garlic provided protection for heart health than processed garlic.

The U.S. Office of Research Integrity received the anonymous tip about potential irregularities in a paper by Das about resveratrol and notified UConn, which set up a special review committee that reviewed six years' worth of his work.

Its report found what it called "a pervasive attitude of disregard within the (lab)" for commonly accepted scientific practices.

It also said there were so many problems - and over so many years - that the review board members "can only conclude that they were the result of intentional acts of data falsification and fabrication, designed to deceive."

Some examples included several cases in which data was digitally altered; data from one experiment was used to justify findings in another; and controls from one experiment were used to denote another experiment's controls, which are the unchanged factors against which experiments are compared.

Austin, the UConn health affairs vice president, said they are "deeply disappointed by the flagrant disregard" for UConn's conduct codes, but grateful that the anonymous tipster notified authorities.

"The abuses in one lab do not reflect the overall performance of the Health Center's biomedical research enterprise, which continues to pursue advances in treatments and cures with the utmost of integrity," Austin said. "We demand full compliance with all research standards and policies by our faculty and staff."

The disclosure comes less than a week after Connecticut authorities finalized an agreement with a Maine-based lab to build a genomic research facility at the UConn Health Center in Farmington as part of a broader plan to expand the medical and dental schools and boost research.

Das' research pre-dates those plans by several years, and is not directly part of the genomic research program.

Explore further: Red wine ingredient resveratrol stops breast cancer growth

shares

Related Stories

Red wine ingredient resveratrol stops breast cancer growth

September 29, 2011
Cheers! A new research report appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the "healthy" ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of ...

UF review of resveratrol studies confirms potential health boost

June 21, 2011
A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable.

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

kochevnik
4.5 / 5 (2) Jan 11, 2012
Transmax is working for me. Made from polygonum cuspidatum, not red wine. Deal is I get an energy boost after midnight. So I'm taking it right before bed on an empty stomach, to get some of the boost during daylight.

To get away from snacking I found hemp seed gives the body the aminos to stave the pangs. Now keeping an ideal weight is easy. People are malnourished, yet eating more of the same processed food only makes them fatter. Meanwhile the hunger remains because the body is deprived. Putting the brain and body at long-term odds with each-other is not a recipe for happiness.
GDM
not rated yet Jan 11, 2012
I still have a glass or three of red wine after dinner, not for longevity, but because I like it. I agree with Kochevnik - people eating these overly flavored and sweetened foods are dying from malnutrition while getting fat. However, I do think Kochevnik should eat something if he is going hungry. Those pangs are your body speaking to you - listen to it.
axemaster
3.7 / 5 (3) Jan 12, 2012
Ugh... if he really needed to falsify data to keep his position, then why not just take a job on Wallstreet? He could have made lots more money, and as we know, their standards aren't very high.
89118a
5 / 5 (1) Jan 15, 2012
"We have a responsibility to correct the scientific record and inform peer researchers across the country," Philip Austin, interim vice president for health affairs, said in a written statement about the notifications to the 11 scientific journals.


Whole heartedly agree. TY for doing this.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.